Actuate Therapeutics Inc (ACTU)

11:40 AM

Using Bollinger Bands to evaluate Actuate Therapeutics Inc.Trade Volume Summary & Long-Term Growth Portfolio Plans - newser.com

11:40 AM

11:03 AM

Actuate Therapeutics Inc. stock retracement – recovery analysisWeekly Trend Report & Entry Point Strategy Guides - newser.com

11:03 AM

10:35 AM

Heatmap analysis for Actuate Therapeutics Inc. and competitorsSell Signal & Safe Entry Trade Reports - newser.com

10:35 AM

Oct 12, 2025

How to forecast Actuate Therapeutics Inc. trends using time series2025 Earnings Surprises & Technical Buy Zone Confirmations - newser.com

Oct 12, 2025

Oct 10, 2025

Risk vs reward if holding onto Actuate Therapeutics Inc.Dollar Strength & Real-Time Market Trend Scan - newser.com

Oct 10, 2025

Oct 10, 2025

How hedge fund analytics apply to Actuate Therapeutics Inc. stock2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Will Actuate Therapeutics Inc. stock see insider buyingPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com

Oct 10, 2025

Oct 10, 2025

Can Actuate Therapeutics Inc. stock deliver sustainable ROETrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Reversal indicators forming on Actuate Therapeutics Inc. stock2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com

Oct 10, 2025

Oct 09, 2025

Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros - Barchart.com

Oct 09, 2025

Oct 08, 2025

Actuate Therapeutics (NASDAQ:ACTU) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 06, 2025

Applying Elliott Wave Theory to Actuate Therapeutics Inc.2025 Momentum Check & Expert Curated Trade Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

Price action breakdown for Actuate Therapeutics Inc.Market Volume Report & Growth Focused Investment Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Is Actuate Therapeutics Inc. trending in predictive chart models2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Evaluating Actuate Therapeutics Inc. with trendline analysisJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com

Oct 06, 2025

Oct 05, 2025

How to build a custom watchlist for Actuate Therapeutics Inc.2025 Top Decliners & AI Based Buy and Sell Signals - newser.com

Oct 05, 2025

Oct 05, 2025

Is Actuate Therapeutics Inc. forming a reversal patternWeekly Earnings Recap & Low Risk Investment Opportunities - newser.com

Oct 05, 2025

Oct 04, 2025

Craig-Hallum Maintains Actuate Therapeutics(ACTU.US) With Buy Rating - 富途牛牛

Oct 04, 2025

Oct 04, 2025

H.C. Wainwright Maintains Actuate Therapeutics(ACTU.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛

Oct 04, 2025

Oct 04, 2025

B.Riley Financial Initiates Actuate Therapeutics(ACTU.US) With Buy Rating, Announces Target Price $20 - 富途牛牛

Oct 04, 2025

Oct 03, 2025

Pancreatic Cancer Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Bio, Keymed Biosciences, Carisma Therapeu - Barchart.com

Oct 03, 2025

Oct 03, 2025

Relative strength of Actuate Therapeutics Inc. in sector analysisPortfolio Return Report & AI Enhanced Execution Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-02 23:42:39 - newser.com

Oct 03, 2025

Oct 01, 2025

Ataxia Telangiectasia Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight - openPR.com

Oct 01, 2025

Sep 30, 2025

Actuate Therapeutics Inc Stock Analysis and ForecastHigh Beta Stocks & Budget Friendly Investment Plans - earlytimes.in

Sep 30, 2025

Sep 30, 2025

Goldman Sachs Group Inc. Has $151,000 Holdings in Actuate Therapeutics, Inc. $ACTU - Defense World

Sep 30, 2025

Sep 29, 2025

Myelofibrosis Market Outlook 2034 – Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight - Barchart.com

Sep 29, 2025

Sep 29, 2025

Myelofibrosis Market Outlook 2034Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight - openPR.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 03:19:58 - newser.com

Sep 29, 2025

Sep 28, 2025

What analysts say about Actuate Therapeutics Inc stockShort-Term Trading Alerts & Trade Like a Pro Using AI Edge - Early Times

Sep 28, 2025